Discover
NBIX
Neurocrine Biosciences, Inc.
161.94
1 x 161.00
1 x 162.02
bid
ask
-
2.98
1.81%
1 @ 04:00 PM
160.95 -0.99 (0.61%)
| Ytd | 14.18% | |
| 1y | 30.62% |
161.78
day range
165.46
122.14
52 week range
186.12
| Open | 165.46 | Prev Close | 164.92 | Low | 161.78 | High | 165.46 | Mkt Cap | 16.28B |
| Vol | 0.00 | Avg Vol | 1.25M | EPS | 6.92 | P/E | 23.40 | Forward P/E | 13.42 |
| Beta | 0.39 | Short Ratio | 4.38 | Inst. Own | 104.14% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | 12-29 | Earning | 07-30 | 50-d Avg | 168.30 | 200-d Avg | 146.64 | 1yr Est | 213.13 |
| Income Statement | |||
| Total Revenue | 959.00M | ||
| Revenues (USD) | 959.00M | ||
| Cost of Revenue | 23.20M | ||
| Gross Profit | 935.80M | ||
| Operating Expenses | 784.30M | ||
| Research and Development Expense | 326.70M | ||
| Selling, General and Administrative Expense | 439.70M | ||
| Operating Income | 151.50M | ||
| Interest Expense | 2.90M | ||
| Income Tax Expense | 17.80M | ||
| Net Income | 144.40M | ||
| Net Income Common Stock | 144.40M | ||
| Net Income Common Stock (USD) | 144.40M | ||
| Consolidated Income | 144.40M | ||
| Earnings per Basic Share | 1.43 | ||
| Earnings per Basic Share (USD) | 1.43 | ||
| Earnings per Diluted Share | 1.39 | ||
| Earning Before Interest & Taxes (EBIT) | 165.10M | ||
| Earning Before Interest & Taxes (USD) | 165.10M | ||
| Weighted Average Shares | 101.00M | ||
| Weighted Average Shares Diluted | 104.20M | ||
| Balance Sheet | |||
| Cash and Equivalents | 332.40M | ||
| Cash and Equivalents (USD) | 332.40M | ||
| Investments | 296.60M | ||
| Investments Current | 57.40M | ||
| Investments Non-Current | 239.20M | ||
| Trade and Non-Trade Receivables | 887.00M | ||
| Current Assets | 1.64B | ||
| Property, Plant & Equipment Net | 538.50M | ||
| Total Assets | 5.36B | ||
| Total Debt | 401.80M | ||
| Current Liabilities | 874.50M | ||
| Debt Non-Current | 401.80M | ||
| Total Liabilities | 1.67B | ||
| Accumulated Retained Earnings (Deficit) | 724.00M | ||
| Accumulated Other Comprehensive Income | 5.10M | ||
| Shareholders Equity | 3.69B | ||
| Shareholders Equity (USD) | 3.69B | ||
| Assets Non-Current | 3.72B | ||
| Total Debt (USD) | 401.80M | ||
| Goodwill and Intangible Assets | 2.73B | ||
| Inventory | 253.30M | ||
| Liabilities Non-Current | 791.00M | ||
| Trade and Non-Trade Payables | 808.30M | ||
| Tax Assets | 8.90M | ||
| Tax Liabilities | 91.50M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 25.70M | ||
| Net Cash Flow from Financing | 63.40M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 64.40M | ||
| Capital Expenditure | -7.80M | ||
| Net Cash Flow - Business Acquisitions and Disposals | -2.36B | ||
| Issuance (Purchase) of Equity Shares | 72.80M | ||
| Issuance (Repayment) of Debt Securities | -6.70M | ||
| Net Cash Flow from Investing | -135.40M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 2.23B | ||
| Net Cash Flow from Operations | 136.40M | ||
| Share Based Compensation | 65.00M | ||